Dentium CO., LTD (KRX:145720)
75,700
-1,400 (-1.82%)
At close: Apr 18, 2025, 3:30 PM KST
Dentium CO., LTD Revenue
In the year 2024, Dentium CO., LTD had annual revenue of 407.81B KRW with 3.72% growth. Dentium CO., LTD had revenue of 118.73B in the quarter ending December 31, 2024, a decrease of -4.42%.
Revenue
407.81B
Revenue Growth
+3.72%
P/S Ratio
1.60
Revenue / Employee
509.76M
Employees
800
Market Cap
651.10B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 407.81B | 14.62B | 3.72% |
Dec 31, 2023 | 393.19B | 37.32B | 10.49% |
Dec 31, 2022 | 355.87B | 64.34B | 22.07% |
Dec 31, 2021 | 291.53B | 61.78B | 26.89% |
Dec 31, 2020 | 229.75B | -22.84B | -9.04% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,547.32B |
Celltrion | 3,557.30B |
ALTEOGEN | 102.85B |
Yuhan | 2,067.79B |
SK Biopharmaceuticals | 547.60B |
HLB Co., Ltd. | 68.13B |
LigaChem Biosciences | 125.90B |
PharmaResearch | 350.12B |